Literature DB >> 2471346

Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.

P H Lange1, M K Brawer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471346

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  7 in total

Review 1.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

2.  Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.

Authors:  M Sheikh; O Al-Saeed; E O Kehinde; T Sinan; J T Anim; Y Ali
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  The changing scenario in diagnosing prostate cancer.

Authors:  D Anitha; T Venkatesh
Journal:  Indian J Clin Biochem       Date:  2000-07

4.  Performance evaluation of a new chemiluminescent assay for prostate specific antigen.

Authors:  A Dasgupta; A Wells; P Datta
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

5.  Evaluation of an automated chemiluminescent immunoassay for complexed PSA on the Bayer ACS:180 system.

Authors:  Pradip Datta; Amitava Dasgupta
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

6.  An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.

Authors:  M C Benson; D J McMahon; W H Cooner; C A Olsson
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Ganoderma tsugae Inhibits the SREBP-1/AR Axis Leading to Suppression of Cell Growth and Activation of Apoptosis in Prostate Cancer Cells.

Authors:  Shih-Yin Huang; Guan-Jhong Huang; Hsi-Chin Wu; Ming-Ching Kao; Wen-Chin Huang
Journal:  Molecules       Date:  2018-10-05       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.